NOT ALL LASERS ARE
THE SAME.
Just because the product or device is marketed as a medical laser does not necessarily
mean it is either the most effective or appropriate for the widest possible variety
of medical conditions. MicrolightLaser®’s patented combination of
the 830nm wavelength and 30mW laser output makes this device unique in its ability
to provide the most effective and efficient therapy.
Laser devices using wavelengths below 810nm or above 860nm are compromised in
their ability to deliver maximum photon energy to the greatest tissue depth.
When treating deep pain or deep tissue injury or disease, the 830nm wavelength
has been shown to have superior ability to effect relief and healing.
Multiple studies have shown that the 830nm wavelength is capable of stimulating
increases in ATP production and pain relieving b-endorphins where other wavelengths
were unable to stimulate these increases.
Clinical evidence is abundant regarding the diminished simulative capability
for devices with very low power output (10mW or less) as well as devices with
excessive power outputs (100mW or greater). The most effective therapeutic window
in terms of power output has been clinically demonstrated to be optimal at the
90mW threshold. The MicrolightLaser® device combines three 30mW laser diodes
to produce this optimal 90mW delivered energy capacity.
We also believe it is important to provide a reliable and durable medical device
to customers. Rather than use plastic or other less durable construction components,
MicrolightLaser® is constructed of high-grade but lightweight metal. This
has proven to be a superior material and allowed us to offer the strongest and
most durable device while still maintaining a very lightweight and user-friendly
device. Other laser devices made of plastic and similar materials are more prone
to breakage and failure.
Clinical studies confirm the 830nm laser wavelength beneficially
increases ATP production, while the 652nm wavelength has no effect
on ATP production.
Noriko Mochizuki-Odaa, Yosky Kataokab, Yilong Cuib, Hisao Yamadab,
Manabu Heyaa, Kunio Awazua
Effects of near-infra-red laser irradiation on adenosine tri-phosphate
and adenosine di-phosphate contents.
Abstract
To investigate the cellular mechanisms by near-infra-red laser
on the nervous system, we examined the effect of 830nm laser
irradiation on the energy metabolism of the rat brain. The
diode laser was applied for 15 min. with an irradiance of 4.8
W/cm2. Tissue adenosine tri-phosphate (ATP) content of the irradiated
area in the cerebral cortex was 19% higher than that of the non-treated
area. Laser irradiation at another wavelength (652nm) had no
effect on either ATP or ADP contents. The temperature
of the tissue was increased by 4.4–4.7 C during the
irradiation of both wavelengths. These results suggest that the increase
in tissue ATP content did not result from the thermal effect,
but from a specific effect of the laser operated at the 830nm
wavelength.
The ATP content of the section irradiated by 830nm with 4.8
W/cm2 for 15 min. was a mean of 20.36 nmol/mg protein, with
a standard
deviation of 3.52 nmol/mg protein (n _ 10; Table 1.A). Although
the contents varied among the animals, the ATP ratio
(irradiated/control; Table 1.A) showed an increase in ATP by
irradiation with the
830nm laser. The paired t-test revealed that the increase
was significant (P value less than 0.05). On the other hand, irradiation
with the 652nm laser resulted in no significant change in the
content of ATP (Table 1.B).
